Search Keyword:


Search option:


IID00698
UniprotP06241
ProteinTyrosine-protein kinase Fyn
GeneFYN
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
537
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 73-148 Monomer :
 Evidence NMR 1zbj A Reference
       Region 1zbj A 84-142 order
 Evidence NMR 1nyg A Reference
       Region 1nyg A 82-83 disorder
       Region 1nyg A 84-141 order
       Region 1nyg A 142-148 disorder
 Evidence NMR 1nyf A Reference
       Region 1nyf A 82-83 disorder
       Region 1nyf A 84-141 order
       Region 1nyf A 142-148 disorder
 Evidence X-RAY 3ua6 B Reference
       Region 3ua6 B 81-82 disorder
       Region 3ua6 B 83-142 order
       Region 3ua6 B 143-143 disorder
 Evidence X-RAY 3ua6 A Reference
       Region 3ua6 A 81-84 disorder
       Region 3ua6 A 85-141 order
       Region 3ua6 A 142-143 disorder
 Evidence X-RAY 3h0i B Reference
       Region 3h0i B 73-83 disorder
       Region 3h0i B 84-142 order
 Evidence X-RAY 3h0i A Reference
       Region 3h0i A 73-83 disorder
       Region 3h0i A 84-142 order
 Evidence X-RAY 3h0h A Reference
       Region 3h0h A 73-79 disorder
       Region 3h0h A 80-142 order
 Evidence X-RAY 3h0f A Reference
       Region 3h0f A 73-83 disorder
       Region 3h0f A 84-142 order
Seq 80-148 Hetero dimer : IID00713Complex
 Evidence NMR 1azg B Reference
       Region 1azg B 82-83 disorder
       Region 1azg B 84-141 order
       Region 1azg B 142-148 disorder
 Evidence NMR 1a0n B Reference
       Region 1a0n B 80-83 disorder
       Region 1a0n B 84-141 order
       Region 1a0n B 142-148 disorder
Seq 81-142 Hetero dimer :
 Evidence X-RAY 1fyn A Reference
       Region 1fyn A 81-142 order
Seq 81-143 Hetero dimer :
 Evidence X-RAY 4eik A Reference
       Region 4eik A 81-83 disorder
       Region 4eik A 84-141 order
       Region 4eik A 142-143 disorder
Seq 81-143 Hetero hexamer : P26663
 Evidence X-RAY 3ua7 A Reference
       Region 3ua7 A 81-143 order
 Evidence X-RAY 3ua7 B Reference
       Region 3ua7 B 81-143 order
 Evidence X-RAY 3ua7 C Reference
       Region 3ua7 C 81-82 disorder
       Region 3ua7 C 83-141 order
       Region 3ua7 C 142-143 disorder
 Evidence X-RAY 3ua7 D Reference
       Region 3ua7 D 81-82 disorder
       Region 3ua7 D 83-143 order
Seq 82-246 Monomer :
 Evidence X-RAY 1g83 B Reference
       Region 1g83 B 82-84 disorder
       Region 1g83 B 85-245 order
       Region 1g83 B 246-246 disorder
 Evidence X-RAY 1g83 A Reference
       Region 1g83 A 82-84 disorder
       Region 1g83 A 85-245 order
       Region 1g83 A 246-246 disorder
Seq 84-141 Hetero tetramer : IID90018Complex
 Evidence X-RAY 4d8d C Reference
       Region 4d8d C 84-141 order
 Evidence X-RAY 4d8d A Reference
       Region 4d8d A 84-84 disorder
       Region 4d8d A 85-141 order
Seq 84-141 Hetero octamer :
 Evidence X-RAY 4znx A Reference
       Region 4znx A 84-141 order
 Evidence X-RAY 4znx B Reference
       Region 4znx B 84-85 disorder
       Region 4znx B 86-141 order
 Evidence X-RAY 4znx C Reference
       Region 4znx C 84-85 disorder
       Region 4znx C 86-141 order
 Evidence X-RAY 4znx D Reference
       Region 4znx D 84-84 disorder
       Region 4znx D 85-141 order
Seq 84-142 Homo tetramer :
 Evidence X-RAY 1shf B Reference
       Region 1shf B 84-142 order
 Evidence X-RAY 1shf A Reference
       Region 1shf A 84-142 order
Seq 84-144 Hetero trimer : IID00694Complex
 Evidence X-RAY 1m27 C Reference
       Region 1m27 C 84-144 order
Seq 85-141 Hetero trimer : IID90018Complex
 Evidence X-RAY 1avz C Reference
       Region 1avz C 85-141 order
Seq 86-143 Hetero tetramer : IID90018Complex
 Evidence X-RAY 1efn C Reference
       Region 1efn C 86-141 order
       Region 1efn C 142-143 disorder
 Evidence X-RAY 1efn A Reference
       Region 1efn A 86-141 order
       Region 1efn A 142-143 disorder
Seq 143-248 Hetero dimer : P03079
 Evidence X-RAY 4u1p A Reference
       Region 4u1p A 148-247 order
       Region 4u1p A 248-248 disorder
 Evidence NMR 1aou F Reference
       Region 1aou F 143-248 order
 Evidence NMR 1aot F Reference
       Region 1aot F 143-248 order
Seq 148-248 Homo dimer :
 Evidence X-RAY 4u17 B Reference
       Region 4u17 B 148-248 order
 Evidence X-RAY 4u17 C Reference
       Region 4u17 C 148-248 order
 Evidence X-RAY 4u17 A Reference
       Region 4u17 A 148-248 order
Seq 148-248 Monomer :
 Evidence NMR 2mrj A Reference
       Region 2mrj A 148-148 disorder
       Region 2mrj A 149-248 order
 Evidence NMR 2mqi A Reference
       Region 2mqi A 148-148 disorder
       Region 2mqi A 149-248 order
Seq 149-248,528-537 Hetero dimer :
 Evidence NMR 2mrk B Reference
       Region 2mrk B 528-537 order
 Evidence NMR 2mrk A Reference
       Region 2mrk A 149-248 order
Seq 261-537 Monomer :
 Evidence X-RAY 2dq7 X Reference
       Region 2dq7 X 261-523 order
       Region 2dq7 X 524-537 disorder
Seqphosphorylation
    21-21 Phosphoserine
    12-12 Phosphothreonine; by PKC
    185-185 Phosphotyrosine
    26-26 Phosphoserine
    531-531 Phosphotyrosine; by CSK
    420-420 Phosphotyrosine; by autocatalysis
 
Prediction
NeProc
Disorder 1-81,528-537
Order 82-527
ProS 1-8,14-17,30-35,45-52,528-537
AlphaFold
Disorder 1-83,262-262,412-412,415-427,525-529,534-537
Order 84-261,263-411,413-414,428-524,530-533
Pfam Hmmer
PF00018 85-141 5.4e-30
PF00017 149-231 2.3e-45
PF07714 271-520 5e-154
SEG 73-86
Function
Function in SwissProt
Non-receptor tyrosine-protein kinase that plays a role in many biological processes including regulation of cell growth and survival, cell adhesion, integrin-mediated signaling, cytoskeletal remodeling, cell motility, immune response and axon guidance. Inactive FYN is phosphorylated on its C-terminal tail within the catalytic domain. Following activation by PKA, the protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1 phosphorylation, activation and targeting to focal adhesions. Involved in the regulation of cell adhesion and motility through phosphorylation of CTNNB1 (beta-catenin) and CTNND1 (delta-catenin). Regulates cytoskeletal remodeling by phosphorylating several proteins including the actin regulator WAS and the microtubule-associated proteins MAP2 and MAPT. Promotes cell survival by phosphorylating AGAP2/PIKE-A and preventing its apoptotic cleavage. Participates in signal transduction pathways that regulate the integrity of the glomerular slit diaphragm (an essential part of the glomerular filter of the kidney) by phosphorylating several slit diaphragm components including NPHS1, KIRREL1 and TRPC6. Plays a role in neural processes by phosphorylating DPYSL2, a multifunctional adapter protein within the central nervous system, ARHGAP32, a regulator for Rho family GTPases implicated in various neural functions, and SNCA, a small pre-synaptic protein. Participates in the downstream signaling pathways that lead to T-cell differentiation and proliferation following T-cell receptor (TCR) stimulation. Phosphorylates PTK2B/PYK2 in response to T-cell receptor activation. Also participates in negative feedback regulation of TCR signaling through phosphorylation of PAG1, thereby promoting interaction between PAG1 and CSK and recruitment of CSK to lipid rafts. CSK maintains LCK and FYN in an inactive form. Promotes CD28-induced phosphorylation of VAV1. In mast cells, phosphorylates CLNK after activation of immunoglobulin epsilon receptor signaling (By similarity).
Biological Process
Diagram with PDB data
FYNFyn SH2 domain in complex with the natural inhibitory phosphotyrosine peptide